Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.
We assayed serial plasma samples from 86 patients, who were enrolled in a prospective randomized trial of the effects of methylprednisolone (MPSS) in septic shock, for the presence of cytokine tumor necrosis factor (TNF) using an enzyme-linked immunosorbent assay. TNF was present in the plasma of 27 of the 74 patients with septic shock, but in only 1 of the 12 patients with shock due to other causes. TNF was detected with equal frequency in patients with shock from gram-negative or from gram-positive bacillary sepsis. TNF levels were highest on the initial sample and decreased significantly over the subsequent 24 h in both the patients treated with MPSS and in those given placebo. Patients with detectable TNF had a higher incidence and severity of the adult respiratory distress syndrome and a higher mortality rate than did patients without detectable TNF.
Marks
J D
JD
Department of Anesthesia, University of California, San Francisco.
Marks
C B
CB
Luce
J M
JM
Montgomery
A B
AB
Turner
J
J
Metz
C A
CA
Murray
J F
JF
D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000209:etiology*; D012769:Shock / Q000097:blood; D012772:Shock, Septic / Q000097:blood* / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
D014409:Tumor Necrosis Factor-alpha; D008775:Methylprednisolone